<p>, /PRNewswire/ -- Robbins LLP 提醒股东，代表所有在 2025 年 10 月 9 日至 2025 年 12 月 11 日期间购买或以其他方式获得 POMDoctor, Ltd. (NASDAQ: POM) 证券的投资者提起了集体诉讼。POMDoctor 声称是 &#34;中国领先的慢性病在线医疗服务平台。&#34;</p>
<p>欲了解更多信息，请提交表格，发送电子邮件给律师 Aaron Dumas, Jr.，或拨打电话 (800) 350-6003。</p>
<p><strong>指控是什么？</strong> Robbins LLP 正在调查 POMDoctor Ltd. (POM) 涉嫌参与泵送和倾倒计划的指控。</p>
<p>根据投诉，在 2025 年 12 月 10 日首次公开募股（&#34;IPO&#34;）前的几周，POMDoctor 的股价从 IPO 价格 4.00 美元飙升至历史最高点 6.09 美元，尽管公司没有任何基本面新闻证明这一涨幅。调查和公开报告随后揭示，POMDoctor 利用社交媒体策划了一场非法的 &#34;泵送和倾倒&#34; 计划以欺诈投资者。据信，冒充合法金融顾问的人在在线论坛、聊天群组和社交媒体帖子中宣传 POMDoctor，发布耸人听闻但毫无根据的声明，以在散户投资者中制造购买狂潮。2025 年 12 月 10 日，POMDoctor 的股价暴跌约 91% 至 0.50 美元。公司的股价继续下滑至约 0.40 美元。</p>
<p>原告声称，在集体诉讼期间，被告未向投资者披露：(i) POMDoctor 是涉及社交媒体虚假信息和冒充金融专业人士的基本股票推广计划的对象；(ii) 内部人士和/或关联方利用离岸或代理账户在价格膨胀活动期间协调倾倒股票；以及 (iii) POMDoctor 的公开声明和风险披露未提及股票价格期间的虚假谣言和人为交易活动。</p>
<p><strong>股东现在可以做什么？</strong> 您可能有资格参与对 POMDoctor Ltd. 的集体诉讼。希望担任集体诉讼主诉人的股东必须在 2026 年 4 月 7 日之前向法院提交相关文件。主诉人是代表其他集体成员指导诉讼的代表方。您不必参与案件即可有资格获得赔偿。如果您选择不采取任何行动，您可以保持缺席集体成员身份。欲了解更多信息，请点击此处。</p>
<p><strong><em>所有代理均基于风险代理费用。股东无需支付任何费用或开支。</em></strong></p>
<p><strong>关于 Robbins LLP</strong>：作为股东权益诉讼的公认领导者，Robbins LLP 的律师和员工自 2002 年以来一直致力于帮助股东追回损失、改善公司治理结构，并追究公司高管的错误行为。</p>
<p>如果您希望在 POMDoctor Ltd. 的集体诉讼达成和解时收到通知，或在公司高管参与不当行为时免费接收警报，请立即注册 Stock Watch。</p>
<p>律师广告。过去的结果并不保证类似的结果。</p>
<p>来源 Robbins LLP</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjI0Jk5ld3NJdGVtSWQ9TEE5NDk3OCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMjQyMDA3UFJfTkVXU19VU1BSX19fX19MQTk0OTc4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjI0Jk5ld3NJdGVtSWQ9TEE5NDk3OCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMjQyMDA3UFJfTkVXU19VU1BSX19fX19MQTk0OTc4"/></p>

<p>Robbins LLP 宣布对在 2025 年 10 月 9 日至 2025 年 12 月 11 日期间购买 POMDoctor, Ltd.（NASDAQ: POM）证券的投资者提起集体诉讼。诉讼指控 POMDoctor 涉嫌参与一个拉抬出货的计划，通过社交媒体宣传误导投资者。在首次公开募股（IPO）价格飙升后，该股票在 2025 年 12 月 10 日暴跌 91%。股东可以通过在 2026 年 4 月 7 日之前提交相关文件参与集体诉讼。Robbins LLP 采用风险代理收费模式，即在未获得赔偿之前不收取任何费用</p>

<p>, /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be &#34;a leading online medical services platform for chronic diseases in China.&#34;</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Robbins LLP 提醒股东，代表所有在 2025 年 10 月 9 日至 2025 年 12 月 11 日期间购买或以其他方式获得 POMDoctor, Ltd. (NASDAQ: POM) 证券的投资者提起了集体诉讼。POMDoctor 声称是 &#34;中国领先的慢性病在线医疗服务平台。&#34;</p>
</div><p>For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.</p>
<div class="lb-trans"><p>欲了解更多信息，请提交表格，发送电子邮件给律师 Aaron Dumas, Jr.，或拨打电话 (800) 350-6003。</p>
</div><p><strong>What are the allegations?</strong> Robbins LLP is Investigating Allegations that POMDoctor Ltd. (POM) was the Subject of a Pump-and-Dump Scheme</p>
<div class="lb-trans"><p><strong>指控是什么？</strong> Robbins LLP 正在调查 POMDoctor Ltd. (POM) 涉嫌参与泵送和倾倒计划的指控。</p>
</div><p>According to the complaint, in the weeks leading up to December 10, 2025 initial public offering (&#34;IPO&#34;), POMDoctor's share price surged from the IPO price of $4.00 to an all-time high of $6.09, despite not fundamental news from the Company justifying the spike. Investigations and public reports have since revealed that POMDoctor utilized social media to orchestrate an illicit &#34;pump-and-dump&#34; scheme to defraud investors. Allegedly, impersonators claiming to be legitimate financial advisors touted POMDoctor in online forums, chat groups, and through social media posts with sensational but baseless claims to create a buying frenzy among retail investors. On December 10, 2025, POMDoctor's share price crashed by approximately 91% to $0.50. The Company's share price has continued to decline to approximately $0.40.</p>
<div class="lb-trans"><p>根据投诉，在 2025 年 12 月 10 日首次公开募股（&#34;IPO&#34;）前的几周，POMDoctor 的股价从 IPO 价格 4.00 美元飙升至历史最高点 6.09 美元，尽管公司没有任何基本面新闻证明这一涨幅。调查和公开报告随后揭示，POMDoctor 利用社交媒体策划了一场非法的 &#34;泵送和倾倒&#34; 计划以欺诈投资者。据信，冒充合法金融顾问的人在在线论坛、聊天群组和社交媒体帖子中宣传 POMDoctor，发布耸人听闻但毫无根据的声明，以在散户投资者中制造购买狂潮。2025 年 12 月 10 日，POMDoctor 的股价暴跌约 91% 至 0.50 美元。公司的股价继续下滑至约 0.40 美元。</p>
</div><p>Plaintiff alleges that during the class period defendants failed to disclose to investors: (i) that POMDoctor was the subject of a fundamental stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (3) that POMDoctor's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity during the stock price.</p>
<div class="lb-trans"><p>原告声称，在集体诉讼期间，被告未向投资者披露：(i) POMDoctor 是涉及社交媒体虚假信息和冒充金融专业人士的基本股票推广计划的对象；(ii) 内部人士和/或关联方利用离岸或代理账户在价格膨胀活动期间协调倾倒股票；以及 (iii) POMDoctor 的公开声明和风险披露未提及股票价格期间的虚假谣言和人为交易活动。</p>
</div><p><strong>What can shareholders do now?</strong> You may be eligible to participate in the class action against POMDoctor Ltd. Shareholders who wish to serve as lead plaintiff for the class must submit their papers to the court by April 7, 2026. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.</p>
<div class="lb-trans"><p><strong>股东现在可以做什么？</strong> 您可能有资格参与对 POMDoctor Ltd. 的集体诉讼。希望担任集体诉讼主诉人的股东必须在 2026 年 4 月 7 日之前向法院提交相关文件。主诉人是代表其他集体成员指导诉讼的代表方。您不必参与案件即可有资格获得赔偿。如果您选择不采取任何行动，您可以保持缺席集体成员身份。欲了解更多信息，请点击此处。</p>
</div><p><strong><em>All representation is on a contingency fee basis. Shareholders pay no fees or expenses.</em></strong></p>
<div class="lb-trans"><p><strong><em>所有代理均基于风险代理费用。股东无需支付任何费用或开支。</em></strong></p>
</div><p><strong>About Robbins LLP</strong>: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.</p>
<div class="lb-trans"><p><strong>关于 Robbins LLP</strong>：作为股东权益诉讼的公认领导者，Robbins LLP 的律师和员工自 2002 年以来一直致力于帮助股东追回损失、改善公司治理结构，并追究公司高管的错误行为。</p>
</div><p>To be notified if a class action against POMDoctor Ltd. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.</p>
<div class="lb-trans"><p>如果您希望在 POMDoctor Ltd. 的集体诉讼达成和解时收到通知，或在公司高管参与不当行为时免费接收警报，请立即注册 Stock Watch。</p>
</div><p>Attorney Advertising. Past results do not guarantee a similar outcome.</p>
<div class="lb-trans"><p>律师广告。过去的结果并不保证类似的结果。</p>
</div><p>SOURCE Robbins LLP</p>
<div class="lb-trans"><p>来源 Robbins LLP</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjI0Jk5ld3NJdGVtSWQ9TEE5NDk3OCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMjQyMDA3UFJfTkVXU19VU1BSX19fX19MQTk0OTc4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA94978&amp;Transmission_Id=202602242007PR_NEWS_USPR_____LA94978&amp;DateId=20260224"/></p>

遭受重大损失的 POM 投资者应联系 Robbins LLP 以获取 Pomdoctor Ltd.证券集体诉讼的相关信息